Core Scientific, Inc. (CORZ) AI Stock Analysis

Core Scientific, Inc. operates digital asset mining facilities and provides colocation services across North America. The company works in blockchain infrastructure through two main segments: Equipment Sales and Hosting. It mines digital assets for its own portfolio and provides hosting services to third-party miners using its datacenter facilities. Core Scientific owns equipment dedicated to processing transactions on blockchain networks and develops blockchain-based platforms for infrastructure management, security, and recordkeeping. Headquartered in Austin, Texas, the company filed for voluntary Chapter 11 reorganization on December 21, 2022.

Core Scientific grew revenue at a 5-year CAGR of 39.5% from FY2020 to FY2025, but annual performance has fluctuated sharply. After revenue reached $640.3M in FY2022 with a net loss of -$2.15B, revenue declined to $502.4M in FY2023 and stood at $510.7M in FY2024. In FY2025, revenue fell 37.5% to $319.0M, with gross margin contracting to 11.9% and operating margin declining to -70.4%, leading to a net loss of -$288.6M and an eps of -$0.50. For the trailing twelve months, revenue totaled $440.3M with an operating margin of 6.9%. In the latest quarter ended June 30, 2026, quarterly revenue growth was 108.8% and quarterly earnings growth was 61.2%.

As of June 30, 2026, Core Scientific held $1.77B in cash and short-term investments against total debt of $4.30B, resulting in net debt of $2.53B. The company has a current ratio of 0.89 and negative shareholders' equity of -$2.42B against total assets of $5.26B. In FY2025, operating cash flow was $278.2M, but free cash flow stood at -$450.8M after capital expenditures of $729.0M. Share count increased 19.8% over 5 years.

Trading at $13.48 as of October 16, 2026, Core Scientific has a market capitalization of $4.33B and an enterprise value of $8.34B. Its forward P/E of 30.7x and price-to-sales ratio of 9.8x trade at a premium to the median of its US-listed Technology peers of 18.8x forward P/E and 2.8x price-to-sales. Its EV/EBITDA of 454.9x also sits well above the peer median of 16.6x. Over the past year, CORZ delivered a return of -31.5%, trailing the S&P 500 return of 16.8%.

Wall Street analysts assign Core Scientific 17 Strong Buy, 3 Buy, and 2 Hold ratings, with 0 Sell or Strong Sell recommendations. The mean price target is $32.62, representing a 142.0% premium over the last close of $13.48. For the current fiscal year ending December 31, 2026, analysts estimate revenue of $675.6M and EPS of -$3.79. For the next fiscal year, 4 analysts estimate revenue of $1.15B and EPS of $0.16. The company beat EPS estimates in 1 of the last 4 quarters, and its next earnings date is November 5, 2026.

This page is an AI-written research summary of Core Scientific, Inc. (CORZ). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: CORZ income statement, CORZ balance sheet, CORZ key metrics, CORZ analyst forecast, CORZ chart. See the CORZ stock overview for the latest quote and news.